Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 23 10:36AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-9.62 Insider Own30.62% Shs Outstand6.35M Perf Week-13.49%
Market Cap19.34M Forward P/E- EPS next Y-1.42 Insider Trans18.09% Shs Float4.40M Perf Month38.41%
Income-21.62M PEG- EPS next Q-1.17 Inst Own0.79% Short Float6.66% Perf Quarter62.83%
Sales0.98M P/S19.73 EPS this Y65.59% Inst Trans10.40% Short Ratio0.03 Perf Half Y-65.28%
Book/sh1.21 P/B2.52 EPS next Y59.54% ROA-131.78% Short Interest0.29M Perf Year-90.99%
Cash/sh0.36 P/C8.44 EPS next 5Y- ROE-214.03% 52W Range0.77 - 35.60 Perf YTD-77.61%
Dividend Est.- P/FCF- EPS past 5Y-25.24% ROI-498.66% 52W High-91.45% Beta0.49
Dividend TTM- Quick Ratio0.71 Sales past 5Y7.76% Gross Margin-49.69% 52W Low295.10% ATR (14)0.63
Dividend Ex-Date- Current Ratio0.71 EPS Y/Y TTM-1.16% Oper. Margin-2086.20% RSI (14)53.30 Volatility17.66% 19.17%
Employees25 Debt/Eq0.62 Sales Y/Y TTM-13.53% Profit Margin-2210.84% Recom1.00 Target Price12.00
Option/ShortNo / Yes LT Debt/Eq0.42 EPS Q/Q26.93% Payout- Rel Volume0.28 Prev Close3.14
Sales Surprise813.33% EPS Surprise19.70% Sales Q/Q96.42% EarningsMay 14 AMC Avg Volume10.11M Price3.05
SMA2012.26% SMA5055.28% SMA200-64.55% Trades Volume587,355 Change-3.03%
Jul-19-24 04:05PM
Jul-18-24 08:45AM
Jul-17-24 08:00AM
Jul-10-24 12:08PM
07:30AM Loading…
Jul-09-24 09:00AM
Jul-08-24 09:00AM
Jun-21-24 08:35AM
Jun-19-24 10:30AM
Jun-18-24 04:48PM
Jun-17-24 09:45AM
07:00AM Loading…
Jun-12-24 07:00AM
Jun-11-24 09:00AM
Jun-10-24 09:00AM
Jun-03-24 09:00AM
May-28-24 08:05AM
May-14-24 04:05PM
May-10-24 04:05PM
May-02-24 08:03AM
Apr-29-24 09:00AM
Apr-25-24 04:05PM
Apr-19-24 12:13PM
Apr-18-24 04:05PM
Apr-17-24 08:00AM
Apr-16-24 01:08PM
08:30AM Loading…
Apr-15-24 08:30AM
Apr-11-24 05:17PM
Apr-08-24 02:15PM
Mar-19-24 04:01PM
Feb-28-24 10:05AM
Feb-27-24 04:05PM
Feb-21-24 04:05PM
Jan-29-24 08:00AM
Dec-22-23 04:05PM
Dec-21-23 10:34AM
Dec-20-23 08:00AM
Nov-14-23 08:17AM
Nov-11-23 09:00AM
Nov-10-23 07:30AM
Nov-03-23 08:00AM
Oct-24-23 08:30AM
Oct-13-23 04:05PM
Oct-12-23 08:00AM
Oct-05-23 07:00AM
Sep-12-23 09:00AM
Sep-11-23 08:00AM
Sep-07-23 08:30AM
Sep-05-23 08:00AM
Aug-29-23 08:00AM
Aug-22-23 08:00AM
Aug-16-23 09:13AM
Aug-14-23 04:05PM
Aug-11-23 07:30AM
Aug-08-23 09:25AM
Aug-07-23 08:00AM
Jul-20-23 08:00AM
Jul-11-23 08:00AM
Jul-10-23 08:00AM
Jul-07-23 09:00AM
Jul-06-23 11:12AM
Jun-27-23 06:07PM
Jun-13-23 08:30AM
May-12-23 08:32AM
May-09-23 05:23PM
May-08-23 08:30AM
Apr-19-23 08:59AM
Mar-14-23 02:38PM
Mar-10-23 08:00AM
Mar-07-23 04:18PM
Mar-06-23 08:30AM
Feb-28-23 08:30AM
Jan-27-23 08:51AM
Jan-19-23 08:35AM
Jan-06-23 09:58AM
Nov-29-22 04:30PM
Nov-16-22 05:32AM
Nov-14-22 08:00AM
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hare JoshuaChief Scientific OfficerApr 11 '24Buy2.3542,553100,000633,280Apr 12 07:00 PM
Soffer RockDirectorApr 11 '24Buy2.3531,91575,000208,534Apr 12 07:00 PM
Hashad Mohamed Wa'el AhmedChief Executive OfficerApr 11 '24Buy2.3510,63824,99919,616Apr 12 07:00 PM
Soffer RockDirectorApr 10 '24Buy2.35106,383250,000176,619Apr 12 07:00 PM
Hare JoshuaChief Scientific OfficerApr 10 '24Buy2.35106,383250,000590,727Apr 12 07:00 PM
Ross CathyDirectorJan 10 '24Buy1.315,0006,54410,000Jan 11 06:00 PM
Baluch KhosoDirectorDec 29 '23Buy1.438,32211,91515,000Jan 02 06:00 PM
PFEFFER JEFFREYDirectorDec 28 '23Buy1.3510,00013,50015,000Dec 29 05:00 PM
Baluch KhosoDirectorDec 28 '23Buy1.401,6782,3426,678Jan 02 06:00 PM
Hare JoshuaChief Scientific OfficerSep 21 '23Option Exercise3.005,00015,0007,828,263Sep 22 07:00 PM
Lehr Paul TGeneral Counsel, SecretarySep 20 '23Option Exercise3.002,0006,000144,213Sep 21 05:00 PM
Hare JoshuaChief Scientific OfficerSep 12 '23Option Exercise3.0030,00090,0007,823,263Sep 14 05:09 PM
Hashad Mohamed Wa'el AhmedChief Executive OfficerSep 12 '23Option Exercise3.0010,00030,00047,566Sep 13 05:00 PM
Soffer RockDirectorSep 08 '23Option Exercise3.0030,00090,000702,351Sep 12 05:00 PM